{
  "meta": {
    "title": "Anti-Epileptic_Drug",
    "url": "https://brainandscalpel.vercel.app/anti-epileptic-drug-2bc5f164.html",
    "scrapedAt": "2025-11-29T18:33:46.186Z"
  },
  "questions": [
    {
      "id": 14586,
      "choices": [
        {
          "id": 58305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parkinsonism</span></span></span></p>"
        },
        {
          "id": 58306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute muscle dystonia</span></span></span></p>"
        },
        {
          "id": 58307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tardive dyskinesia</span></span></span></p>"
        },
        {
          "id": 58308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Akathisia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Propranolol is useful in the management of which of the following side effects of a typical neuroleptic?</span></span></span></p>",
      "unique_key": "Q5652478",
      "question_audio": null,
      "question_video": null,
      "map_id": 36207,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Akathisia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Propranolol, </strong>a<strong> non-selective beta-blocker,</strong> is useful in the management of<strong> akathisia,</strong> which is a<strong> common side effect</strong> of <strong>typical neuroleptics (antipsychotic drugs).</strong> Akathisia is characterized by a <strong>subjective feeling of restlessness</strong> and an<strong> objective need to move</strong>, often<strong> resulting in</strong> <strong>pacing and inability to sit still</strong>. <strong>Propranolol </strong>helps <strong>alleviate </strong>these symptoms by <strong>blocking beta-adrenergic receptors</strong>, which can<strong> modulate </strong>some of the pathways involved in <strong>akathisia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Parkinsonism:</span></strong><span style=\"font-size:12.0pt\"> Parkinsonism induced by<strong> neuroleptics </strong>is <strong>treated</strong> with <strong>anticholinergic medications</strong>, not beta-blockers like propranolol.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Acute muscle dystonia:</span></strong><span style=\"font-size:12.0pt\"> Acute dystonia resulting from <strong>neuroleptic use</strong> is usually <strong>treated </strong>with<strong> anticholinergic agents</strong> <strong>or benzodiazepines</strong>, not beta-blockers.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tardive dyskinesia:</span></strong><span style=\"font-size:12.0pt\"> Tardive dyskinesia is a<strong> late-onset movement disorder </strong>caused by<strong> long-term use of neuroleptics</strong>. Treatment options may include <strong>reducing the dose</strong> of the <strong>neuroleptic,</strong> <strong>switching</strong> to a <strong>less potent agent,</strong> or using medications like <strong>valbenazine or</strong> <strong>deutetrabenazine, </strong>not typically beta-blockers.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The educational objective is to recognize that <strong>propranolol,</strong> a<strong> beta-blocker,</strong> is <strong>effective</strong> in <strong>managing akathisia,</strong> a <strong>side effect</strong> characterized by<strong> restlessness and an uncontrollable</strong> need to<strong> move</strong>, often associated with the<strong> use of typical neuroleptics. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of extrapyramidal symptoms:</span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-172358.jpg\" style=\"height:386px; width:1000px\" /></span></span></strong></p>",
      "correct_choice_id": 58308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14484,
      "choices": [
        {
          "id": 57897,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polycystic ovarian syndrome </span></span></span></p>"
        },
        {
          "id": 57898,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alopecia</span></span></span></p>"
        },
        {
          "id": 57899,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight loss </span></span></span></p>"
        },
        {
          "id": 57900,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tremor</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which one of the following is a gender specific side effect of valproate? </span></span></span></p>",
      "unique_key": "Q2247699",
      "question_audio": null,
      "question_video": null,
      "map_id": 36193,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Polycystic ovarian syndrome</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Valproate</strong>, an <strong>antiepileptic drug</strong> used to<strong> treat seizures and mood disorders</strong>, has been associated with the <strong>development of polycystic</strong> <strong>ovarian syndrome (PCOS) in women</strong>. PCOS is characterized by the<strong> presence of ovarian cysts, irregular menstrual cycles,</strong> and <strong>elevated androgen levels,</strong> which can<strong> lead to</strong> symptoms such as<strong> hirsutism and acne.</strong> The <strong>link between</strong> <strong>valproate and PCOS </strong>is particularly noted in <strong>young women</strong> who use the<strong> drug over long periods, </strong>making it a significant<strong> gender-specific side effect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Alopecia:&nbsp;</span></strong><span style=\"font-size:12.0pt\">While <strong>hair loss</strong> is a known side effect of <strong>valproate</strong>, it is not gender-specific.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Weight loss:&nbsp;</span></strong><span style=\"font-size:12.0pt\"><strong>Weight gain</strong>, rather than loss, is <strong>more </strong>commonly associated <strong>with valproate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Tremor:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This <strong>side effec</strong>t is not gender-specific and can affect <strong>anyone taking valproate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The use of <strong>valproate in young women </strong>needs <strong>careful </strong>consideration <strong>due to the risk of inducing polycystic ovarian syndrome, </strong>a <strong>serious and gender-specific side effect</strong>, underscoring the need for <strong>monitoring </strong>and possibly<strong> seeking alternative treatments</strong> where <strong>feasible.</strong></span></span></p>",
      "correct_choice_id": 57897,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14608,
      "choices": [
        {
          "id": 58393,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rivastigmine</span></span></span></p>"
        },
        {
          "id": 58394,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Donepezil</span></span></span></p>"
        },
        {
          "id": 58395,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Memantine</span></span></span></p>"
        },
        {
          "id": 58396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Galantamine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following agents is available as a patch for once-daily use and is likely to provide steady drug levels to treat Alzheimer&rsquo;s disease? </span></span></span></p>",
      "unique_key": "Q8627601",
      "question_audio": null,
      "question_video": null,
      "map_id": 36192,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Rivastigmine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Rivastigmine</strong> is a newer reversible<strong> anticholinesterase</strong> indicated for the <strong>treatment of dementia and Alzheimer&rsquo;s disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It has<strong> better CNS penetration</strong> than other drugs of this group. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is the only agent available as a<strong> transdermal patch</strong> for the<strong> treatment of Alzheimer&rsquo;s disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It may also be <strong>used for dementia </strong>associated with <strong>Parkinson&rsquo;s disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is applied<strong> every 24 hours </strong>to<strong> improve patient compliance.&nbsp;</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58393,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14571,
      "choices": [
        {
          "id": 58245,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Give propranolol.</span></span></span></p>"
        },
        {
          "id": 58246,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase dose of haloperidol</span></span></span></p>"
        },
        {
          "id": 58247,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reassurance</span></span></span></p>"
        },
        {
          "id": 58248,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Give benzhexol.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A patient of schizophrenia was prescribed haloperidol. Next day, he presented to the hospital with the features shown in the figure. What should be the treatment?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/picture6.jpg\" style=\"height:300px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q9547388",
      "question_audio": null,
      "question_video": null,
      "map_id": 36204,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"margin-right:-1px; text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Give benzhexol.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This figure shows <strong>torticollis</strong>. It is an <strong>acute muscular dystonia</strong>, an <strong>extrapyramidal side effect of typical antipsychotics. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This<strong> can </strong>appear <strong>within a few hours</strong> after the<strong> administration of antipsychotic drugs</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Extrapyramidal side effects</strong> are seen<strong> more </strong>commonly with the <strong>use of high potency </strong>drugs like <strong>haloperidol and fluphenazine. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Benzhexol </strong>is the<strong> drug of choice</strong> for<strong> acute muscular dystonia.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-164806.jpg\" style=\"height:465px; width:1000px\" /></span></span></span></p>",
      "correct_choice_id": 58248,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14452,
      "choices": [
        {
          "id": 57769,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levodopa is an active metabolite of dopamine.</span></span></span></p>"
        },
        {
          "id": 57770,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">About 50% of administered levodopa is peripherally converted to carbidopa.</span></span></span></p>"
        },
        {
          "id": 57771,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">About 2 % of the administered levodopa crosses blood brain barrier.&nbsp;&nbsp;</span></span></span></p>"
        },
        {
          "id": 57772,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Levodopa is a first line drug in the treatment of hepatic coma.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">True about anti - Parkinson drug levodopa is?</span></span></span></p>",
      "unique_key": "Q3056515",
      "question_audio": null,
      "question_video": null,
      "map_id": 36205,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) About 2% of the administered levodopa crosses the blood brain border.&nbsp;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Levodopa</strong> is <strong>effectively used</strong> in the treatment of <strong>Parkinson&rsquo;s disease,</strong> primarily because it serves as a <strong>precursor to dopamine,</strong> a <strong>neurotransmitter</strong> that is <strong>deficient in patients with Parkinson&#39;s. Once administered, levodopa </strong>is<strong> converted</strong> into <strong>dopamine</strong> within the <strong>brain to alleviate symptoms </strong>such as <strong>tremors, rigidity, and bradykinesia</strong>. However, the challenge with<strong> levodopa</strong> treatment is its limited ability to<strong> cross the blood-brain barrier</strong>&mdash;only about <strong>1-3% of administered levodopa </strong>reaches the brain. To improve this <strong>delivery and increase the amount of levodopa</strong> reaching the<strong> brain,</strong> it is often <strong>administered with carbidopa,</strong> an <strong>inhibitor </strong>of the enzyme (aromatic <strong>L-amino acid decarboxylase</strong>) that <strong>converts levodopa to dopamine</strong> <strong>outside the brain.</strong> This<strong> inhibition prevents</strong> the <strong>peripheral metabolism of levodopa, </strong>thereby <strong>allowing more</strong> of it to <strong>cross into the brain </strong>where <strong>it can be effective.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Levodopa is an active metabolite of dopamine:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect,</strong> as <strong>levodopa is not a metabolite</strong> <strong>but a precursor </strong>that is <strong>converted to dopamine in the brain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. About 50% of administered levodopa is peripherally converted to carbidopa:</span></strong><span style=\"font-size:12.0pt\"><strong> Incorrect,</strong> carbidopa is <strong>not</strong> a product of <strong>levodopa metabolism</strong> but is <strong>rather</strong> used to<strong> inhibit the peripheral conversion of levodopa to dopamine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Levodopa is a first-line drug in the treatment of hepatic coma:</span></strong><span style=\"font-size:12.0pt\"> <strong>Incorrect, </strong>as levodopa <strong>is not</strong> used for <strong>hepatic coma</strong>, which is related to<strong> liver failure </strong>and<strong> not </strong>typically managed<strong> </strong>with<strong> dopamine precursors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only a <strong>small fraction (about 1-3%) </strong>of administered <strong>levodopa crosses the blood-brain barrier</strong> to become <strong>active in the brain,</strong> necessitating the<strong> co-administration of carbidopa</strong> to<strong> inhibit its peripheral metabolism</strong> and <strong>increase its central availability</strong> and <strong>effectiveness</strong> in<strong> treating Parkinson&#39;s disease.</strong></span></span></p>",
      "correct_choice_id": 57771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14601,
      "choices": [
        {
          "id": 58365,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tachycardia</span></span></span></p>"
        },
        {
          "id": 58366,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Respiratory depression</span></span></span></p>"
        },
        {
          "id": 58367,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Urinary retention</span></span></span></p>"
        },
        {
          "id": 58368,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe itching</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient is operated on for bile duct stricture. Post operatively he is receiving 3 ml epidural morphine for pain relief. One day he accidentally received 12 ml of morphine. What will not occur? </span></span></p>",
      "unique_key": "Q3760613",
      "question_audio": null,
      "question_video": null,
      "map_id": 36190,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Tachycardia</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Epidural administration of morphine</strong> can provide <strong>excellent pain relief, </strong>but it <strong>can</strong> also <strong>lead to adverse effects</strong> such as <strong>respiratory depression, urinary retention, and pruritus </strong>(<strong>severe itching</strong>). The <strong>risk </strong>of <strong>adverse effects is higher</strong> if the patient receives an <strong>overdose of morphine</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Tachycardia </strong>is <strong>not</strong> a<strong> common adverse effect of morphine</strong>, and it is<strong> not </strong>expected to occur in response to an <strong>overdose.</strong> Rather<strong> bradycardia </strong>can be seen<strong> due to depression of cardiovascular centre in brain.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Vomiting and retching</strong> are <strong>common adverse effects of morphine</strong> and can <strong>occur</strong> with an <strong>overdose. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Respiratory depression</strong> is the most significant <strong>adverse effect of morphine </strong>and can be <strong>life-threatening in severe cases. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Urinary retention </strong>is another common <strong>adverse effect</strong> of morphine that occurs due to the <strong>inhibition of bladder</strong> <strong>contractions. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Severe itching, or pruritus,</strong> is another common <strong>adverse effect of morphine</strong> that can be<strong> bothersome</strong> for the patient.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14505,
      "choices": [
        {
          "id": 57981,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cardiac anomalies </span></span></span></p>"
        },
        {
          "id": 57982,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Neural defects </span></span></span></p>"
        },
        {
          "id": 57983,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Facial defects </span></span></span></p>"
        },
        {
          "id": 57984,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urogenital malformations</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 30-year-old pregnant woman with a history of bipolar disorder has been taking lithium throughout her pregnancy. Her neonate should be screened for which of the following?</span></span></span></p>",
      "unique_key": "Q4598704",
      "question_audio": null,
      "question_video": null,
      "map_id": 36197,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Cardiac anomalies.</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lithium</strong> use <strong>during pregnancy, </strong>especially during the <strong>first trimester,</strong> is associated with an <strong>increased risk of congenital cardiac</strong> <strong>anomalies in the neonate,</strong> most <strong>notably Ebstein&#39;s anomaly,</strong> which is a<strong> rare heart defect </strong>affecting the<strong> tricuspid valve and right side of the heart</strong>. Therefore, <strong>neonates born to mothers </strong>who have taken<strong> lithium</strong> during <strong>pregnancy </strong>should be<strong> closely monitored</strong> and <strong>screened for cardiac anomalies.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Neural defects</span></strong><span style=\"font-size:12.0pt\">: While<strong> important to screen</strong> for in <strong>general, neural tube defects</strong> are <strong>more closely </strong>associated with medications like<strong> valproate and carbamazepine </strong>rather than lithium.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Facial defects</span></strong><span style=\"font-size:12.0pt\">: Facial defects, such as<strong> cleft lip and palate,</strong> are<strong> not</strong> specifically associated with <strong>lithium </strong>use <strong>during pregnancy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Urogenital malformations</span></strong><span style=\"font-size:12.0pt\">: While it&#39;s important to screen for <strong>urogenital malformations in neonates </strong>for a variety of reasons, <strong>lithium use in pregnancy</strong> is specifically noted for its association with <strong>cardiac anomalies</strong> rather than urogenital malformations.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The educational goal is to recognize the <strong>teratogenic risks </strong>associated with the <strong>use of lithium</strong> during <strong>pregnancy, </strong>particularly the <strong>increased risk of cardiac anomalies</strong> such as<strong> Ebstein&#39;s anomaly in the neonate.</strong></span></span></span></p>",
      "correct_choice_id": 57981,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14582,
      "choices": [
        {
          "id": 58289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is highly protein bound.</span></span></span></p>"
        },
        {
          "id": 58290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Its half-life increases with increase in dose.</span></span></span></p>"
        },
        {
          "id": 58291,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a microsomal enzyme inducer.</span></span></span></p>"
        },
        {
          "id": 58292,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It follows zero order kinetics at lower doses.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">False statement regarding phenytoin is?</span></span></span></p>",
      "unique_key": "Q5559169",
      "question_audio": null,
      "question_video": null,
      "map_id": 36206,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) It follows zero order kinetics at lower doses</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The<strong> false statement </strong>regarding phenytoin is that it<strong> follows zero order kinetics at lower doses. Phenytoin </strong>actually<strong> exhibits zero order</strong> <strong>kinetics at higher,</strong> often <strong>therapeutic, doses</strong>. This<strong> means</strong> that the drug is<strong> metabolized at a constant rate </strong>regardless of <strong>concentration,</strong> and the <strong>liver&#39;s capacity to metabolize the drug is saturated.</strong> At <strong>lower doses, phenytoin </strong>generally follows <strong>first order kinetics,</strong> where the<strong> rate of drug metabolism</strong> is <strong>proportional to its concentration.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. It is highly protein bound</span></strong><span style=\"font-size:12.0pt\">: This is<strong> true.</strong> <strong>Phenytoin</strong> is approximately<strong> 90% bound to plasma proteins, </strong>and because of this, it can be <strong>displaced by other drugs,</strong> leading to an<strong> increase in the concentration of free (active) phenytoin.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Its half-life increases with increase in dose</span></strong><span style=\"font-size:12.0pt\">: This is <strong>true</strong> and is related to <strong>phenytoin&#39;s zero order kinetics </strong>at <strong>therapeutic or higher doses</strong>. As the <strong>dose increases</strong>, the <strong>half-life becomes longer</strong> because the<strong> drug-metabolizing enzymes in the liver </strong>become <strong>saturated.</strong></span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. It is a microsomal enzyme inducer</span></strong><span style=\"font-size:12.0pt\">: This is <strong>true</strong>. <strong>Phenytoin</strong> induces<strong> hepatic</strong> <strong>microsomal enzymes,</strong> which can lead to<strong> increased metabolism of other drugs</strong>, potentially <strong>requiring dose adjustments</strong> of<strong> concomitant medications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational goal is to understand the<strong> pharmacokinetics of phenytoin</strong>, an<strong> antiepileptic</strong> <strong>drug.</strong> At <strong>lower doses,</strong> phenytoin follows<strong> first order kinetics</strong>, but as the<strong> dose increases </strong>and <strong>reaches therapeutic levels</strong>, it <strong>exhibits zero order kinetics</strong> where the <strong>drug is metabolized </strong>at a <strong>constant rate.</strong></span></span></p>",
      "correct_choice_id": 58292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14489,
      "choices": [
        {
          "id": 57917,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Change atenolol and imipramine to ACE inhibitor and fluoxetine and add bisacodyl for constipation.</span></span></span></p>"
        },
        {
          "id": 57918,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Change imipramine and haloperidol to fluoxetine and risperidone and add bisacodyl for constipation.</span></span></span></p>"
        },
        {
          "id": 57919,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only add bisacodyl for constipation and continue the rest of the medications.</span></span></span></p>"
        },
        {
          "id": 57920,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Discontinue all her medications and start her on steroids.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">An 86-year-old lady presented with severe constipation. She was a known hypertensive on medications for 10 years. In the clinic, her BP was 157/98 mm Hg on supine position with a heart rate of 48 beats per minute. On taking her BP in the sitting position, it was found to be 90/60 mm Hg. She had a recent history of depression. She is taking atenolol, thiazide, imipramine, haloperidol, and docusate. What will be the next best step in the management?</span></span></span></p>",
      "unique_key": "Q2633914",
      "question_audio": null,
      "question_video": null,
      "map_id": 36195,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Change atenolol and imipramine to ACE inhibitor and fluoxetine and add bisacodyl for constipation.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This patient&#39;s presentation of <strong>bradycardia, postural hypotension, and severe constipation </strong>suggests <strong>adverse effects </strong>from her current medications. <strong>Atenolol, a beta-blocker,</strong> can <strong>cause bradycardia and exacerbate postural hypotension,</strong> while <strong>imipramine</strong>, a <strong>tricyclic</strong> <strong>antidepressant</strong>, is known to cause<strong> both constipation and postural hypotension.</strong>Therefore to address these cocerns we will like to <strong>change the culprit drugs atenolol and imipramine</strong> to relatively <strong>better drugs without </strong>these <strong>adverse effects.&nbsp;</strong></span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Switching from atenolol</strong> to an <strong>ACE inhibitor</strong> may <strong>better control</strong> <strong>her hypertension</strong> <strong>without</strong> causing<strong> bradycardia. Replacing imipramine with fluoxetine,</strong> a <strong>selective serotonin reuptake inhibitor,</strong> could help manage her <strong>depression without contributing </strong>to <strong>constipation or postural</strong> <strong>hypotension</strong>. Though <strong>ACE inhibitors</strong> also can<strong> cause postural hypotension</strong> but the<strong> risk is quite negligible </strong>as compared to<strong> alpha</strong> <strong>blockers and TCAs</strong>. Adding<strong> bisacodyl</strong> will address<strong> her immediate</strong> need for<strong> relief from severe constipation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:16px\">&nbsp;other options:</span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Change imipramine and haloperidol to fluoxetine and risperidone and add bisacodyl for constipation.</span></strong><span style=\"font-size:12.0pt\">&nbsp;Changing imiparmine to fluoxetine will <strong>solve the problem of constipatoin </strong>but it<strong> does not </strong>address the <strong>hypertension or bradycardia effectively.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-size:16px\"><strong>Only add bisacodyl for constipation and continue the rest of the medications:</strong></span>&nbsp;It <strong>addresses</strong> the problem of <strong>costipation</strong> partly but <strong>d</strong></span><span style=\"font-size:12.0pt\"><strong>oes not resolve </strong>the <strong>other underlying issues </strong>causing <strong>her symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D<span style=\"font-size:16px\">:&nbsp;</span></span><span style=\"font-size:16px\"><span dir=\"ltr\" lang=\"EN-US\">Discontinue all her medications and start her on steroids:</span></span></strong><span style=\"font-size:12.0pt\">&nbsp;It Is<strong> inappropriate and potentially harmful.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Management of polypharmacy </strong>in elderly patients requires<strong> careful consideration </strong>of the <strong>side effects </strong>of <strong>each medication</strong>, especially when they contribute to conditions like<strong> constipation, postural hypotension, and bradycardia</strong>. <strong>Adjustments </strong>should<strong> aim to minimize</strong> <strong>these effects</strong> while<strong> effectively treating </strong>the<strong> underlying conditions</strong></span></span></span></p>",
      "correct_choice_id": 57917,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14510,
      "choices": [
        {
          "id": 58001,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">HLA-B 1507</span></span></span></p>"
        },
        {
          "id": 58002,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">HLA-B 1502</span></span></span></p>"
        },
        {
          "id": 58003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HLA-B 57</span></span></span></p>"
        },
        {
          "id": 58004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HLA-B</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The risk of carbamazepine induced Stevens Johnson syndrome is increased in the presence of which of the following gene? </span></span></span></p>",
      "unique_key": "Q7144228",
      "question_audio": null,
      "question_video": null,
      "map_id": 36199,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) HLA-B 1502</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Carbamazepine-induced Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) </strong>are serious <strong>skin reactions</strong> that can be <strong>life-threatening.</strong> These conditions are significantly <strong>more likely </strong>to occur in individuals who have the<strong> HLA-B 1502 gene variant. </strong>This <strong>genetic marker</strong> is notably <strong>prevalent in populations</strong> of <strong>Asian descent</strong>, leading to <strong>heightened risk assessments </strong>and <strong>screening</strong> recommendations before the<strong> administration of carbamazepine</strong> in these populations. Testing for the <strong>presence of HLA-B 1502</strong> is recommended to <strong>prevent the initiation of carbamazepine in patients </strong>at <strong>increased risk of developing SJS/TEN,</strong> thereby <strong>enhancing</strong> <strong>patient safety.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Screening</strong> for the <strong>HLA-B 1502 gene</strong> variant in patients who are<strong> candidates for carbamazepine therapy,</strong> particularly those of<strong> Asian</strong> <strong>ancestry,</strong> is crucial in <strong>reducing the risk of potentially fatal skin reactions</strong> such as<strong> Stevens-Johnson syndrome</strong> and <strong>toxic epidermal</strong> <strong>necrolysis.</strong> This <strong>preemptive </strong>approach is a<strong> vital component of personalized medicine</strong>, aimed at ensuring the <strong>safety and efficacy </strong>of drug treatments.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/10/screenshot-2024-05-10-155355.jpg\" style=\"height:684px; width:1000px\" /></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>",
      "correct_choice_id": 58002,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14460,
      "choices": [
        {
          "id": 57801,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Benzodiazepines act on the midbrain, ascending reticular formation, and limbic system. </span></span></span></p>"
        },
        {
          "id": 57802,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Benzodiazepines exert their effects through the GABA A receptors. </span></span></span></p>"
        },
        {
          "id": 57803,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Benzodiazepines increase the conductance of CI- channels. </span></span></span></p>"
        },
        {
          "id": 57804,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Benzodiazepines have GABA-mimetic action.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following statements is not true about the mechanism of action of benzodiazepines? </span></span></span></p>",
      "unique_key": "Q6652965",
      "question_audio": null,
      "question_video": null,
      "map_id": 36208,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Benzodiazepines have GABA-mimetic action.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Benzodiazepines </strong>are <strong>allosteric modulators of the GABA A receptor;</strong> they <strong>enhance </strong>the action of <strong>GABA</strong> but <strong>do not mimic its effects</strong> directly. By<strong> binding </strong>to their s<strong>pecific site on the GABA A receptor complex,</strong> benzodiazepines <strong>increase the frequency of chloride</strong> <strong>channel opening</strong> events when GABA is present, thereby <strong>enhancing the hyperpolarization </strong>and resulting in <strong>decreased neuronal</strong> <strong>excitability.</strong> They<strong> do not, </strong>however, <strong>activate these receptors independently</strong> like<strong> GABA (GABA-mimetic action), </strong>which is a <strong>distinction</strong> <strong>particularly important</strong> when<strong> comparing them to barbiturates </strong>that have <strong>both GABA facilitatory and mimetic actions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A, B, C:</span></strong><span style=\"font-size:12.0pt\"> <strong>All these statements correctly </strong>describe the<strong> action of benzodiazepines</strong> as they highlight the <strong>enhancement of</strong> <strong>GABAergic transmission</strong> through <strong>allosteric modulation of GABA A receptors</strong>,<strong> influencing chloride ion flow </strong>and<strong> impacting</strong> areas of the <strong>brain </strong>involved in<strong> anxiety and arousal regulation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Benzodiazepines</strong> <strong>enhance </strong>but <strong>do not mimic </strong>the<strong> action of GABA,</strong> functioning as <strong>allosteric modulators </strong>rather than direct agonists of <strong>GABA A receptors,</strong> which is <strong>crucial for understanding </strong>their<strong> safety profile and therapeutic effects.</strong></span></span></p>",
      "correct_choice_id": 57804,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14479,
      "choices": [
        {
          "id": 57877,
          "text": "<p>&nbsp;<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cocaine</span></span></span></p>"
        },
        {
          "id": 57878,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amphetamine</span></span></span></p>"
        },
        {
          "id": 57879,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cannabis</span></span></span></p>"
        },
        {
          "id": 57880,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamphetamine</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CNS stimulants are all except?</span></span></p>",
      "unique_key": "Q6399515",
      "question_audio": null,
      "question_video": null,
      "map_id": 36191,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Cannabis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>CNS stimulants </strong>are characterized by their<strong> ability to increase alertness</strong>, <strong>energy, and attention.</strong> <strong>Cocaine, amphetamine,</strong> and <strong>dexamphetamine</strong> are classic examples of<strong> CNS stimulants </strong>used<strong> medically to treat </strong>conditions like<strong> ADHD and narcolepsy.</strong> <strong>Cannabis,</strong> however,<strong> primarily acts as a CNS depressant</strong> with some <strong>stimulant qualities</strong>, but it<strong> does not</strong> fit the typical profile of a<strong> CNS stimulant</strong> that <strong>enhances mental and physical functions</strong>. <strong>Instead, </strong>it is<strong> known for its sedative </strong>and <strong>psychoactive effects</strong>, which can lead to <strong>relaxation and altered sensory perceptions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A, B, D:</span></strong><span style=\"font-size:12.0pt\"> <strong>Cocaine, amphetamine, and dexamphetamine</strong> all<strong> stimulate the central nervous system</strong> by<strong> increasing levels of</strong> <strong>dopamine and norepinephrine </strong>in the brain, thus <strong>enhancing activity, mood, and alertness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Cannabis does not</strong> function <strong>primarily as a CNS stimulant </strong>and<strong> should not</strong> be classified alongside drugs like <strong>amphetamines and</strong> <strong>cocaine</strong>, which are<strong> direct stimulants of the central nervous system</strong></span></span></span></p>",
      "correct_choice_id": 57879,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14508,
      "choices": [
        {
          "id": 57993,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thrombocytopenia</span></span></span></p>"
        },
        {
          "id": 57994,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hepatotoxicity</span></span></span></p>"
        },
        {
          "id": 57995,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperammonemia</span></span></span></p>"
        },
        {
          "id": 57996,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pancreatitis</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If carbamazepine is added to valproate, which of the following side- effects increases?&nbsp; </span></span></span></p>",
      "unique_key": "Q8245977",
      "question_audio": null,
      "question_video": null,
      "map_id": 36198,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Hepatotoxicity</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Valproate</strong> is known to be <strong>metabolized by the liver</strong> through the<strong> cytochrome P450 enzyme </strong>system. A<strong> minor but</strong> significant <strong>hepatotoxic metabolite</strong> is produced during this process. <strong>When carbamazepine</strong>, a <strong>known enzyme inducer</strong>, is added to <strong>valproate</strong> <strong>therapy,</strong> it can <strong>enhance the activity</strong> of these <strong>liver enzymes</strong>, leading to<strong> increased production of the hepatotoxic metabolite.</strong> This <strong>interaction</strong> <strong>raises </strong>the<strong> risk of liver damage</strong>, making <strong>hepatotoxicity </strong>a significant concern when these <strong>two medications</strong> are used <strong>concurrently.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Thrombocytopenia:</span></strong><span style=\"font-size:12.0pt\"> Although <strong>valproate</strong> can cause <strong>thrombocytopenia,</strong> there is <strong>no direct enhancement </strong>of this risk <strong>due to</strong> <strong>carbamazepine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Hyperammonemia:</span></strong><span style=\"font-size:12.0pt\"> While <strong>valproate</strong> can cause<strong> hyperammonemia</strong>, <strong>carbamazepine does not</strong> typically <strong>exacerbate </strong>this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pancreatitis:</span></strong><span style=\"font-size:12.0pt\"><strong> Both drugs</strong> have been associated with <strong>pancreatitis,</strong> but the <strong>combination does not </strong>specifically <strong>increase this</strong> <strong>risk</strong> compared to <strong>each drug alone.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">When<strong> combining carbamazepine with valproate,</strong> <strong>careful monitoring of liver function </strong>is essential due to the <strong>increased risk of</strong> <strong>hepatotoxicity</strong> from enhanced<strong> metabolism and production of a toxic metabolite.</strong></span></span></span></p>",
      "correct_choice_id": 57994,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14513,
      "choices": [
        {
          "id": 58013,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vivid dreaming </span></span></span></p>"
        },
        {
          "id": 58014,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anorgasmia </span></span></span></p>"
        },
        {
          "id": 58015,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bradycardia </span></span></span></p>"
        },
        {
          "id": 58016,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nausea</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A bank employee suffering from depression came to AIIMS OPD. He was started on Escitalopram. Which of the following adverse effects cannot be explained with Escitalopram?</span></span></span></p>",
      "unique_key": "Q3944713",
      "question_audio": null,
      "question_video": null,
      "map_id": 36200,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Bradycardia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Escitalopram,</strong> a commonly used <strong>selective serotonin reuptake inhibitor (SSRI), </strong>has various known <strong>side effects</strong> that impact<strong> both the</strong> <strong>central nervous system </strong>and other <strong>bodily functions</strong>, but <strong>bradycardia</strong> is<strong> not </strong>typically one of them. Instead, <strong>SSRIs like Escitalopram </strong>are <strong>more </strong>likely to <strong>cause side effects</strong> such as:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Vivid dreaming:</span></strong><span style=\"font-size:12.0pt\"> This can be a result of<strong> increased serotonin levels </strong>affecting various<strong> neurotransmitter pathways,</strong> including those that<strong> influence sleep and dreaming.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Anorgasmia:</span></strong><span style=\"font-size:12.0pt\"><strong> Sexual dysfunction</strong> is a well-documented<strong> side effect of SSRIs</strong>, which can<strong> interfere </strong>with <strong>sexual arousal</strong> and <strong>orgasm,</strong> likely through their <strong>effects on serotonin receptors</strong> that<strong> impact sexual function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nausea:</span></strong><span style=\"font-size:12.0pt\"> This is a <strong>common initial side effect</strong> when<strong> starting SSRIs, </strong>resulting from the <strong>increased serotonin activity</strong> in the <strong>gastrointestinal tract.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Bradycardia, </strong>or a<strong> slower than normal heart rate,</strong> is <strong>not</strong> a typical reaction to <strong>Escitalopram</strong>. <strong>SSRIs</strong> can cause some<strong> cardiovascular</strong> <strong>effects</strong>, but they are<strong> more</strong> commonly associated with <strong>mild tachycardia</strong> rather than bradycardia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While <strong>Escitalopram </strong>is<strong> effective for treating depression </strong>and associated symptoms like <strong>anxiety,</strong> its <strong>adverse effects</strong> can <strong>impact sexual</strong> <strong>function, sleep, and gastrointestinal health</strong> but<strong> not </strong>typically<strong> heart rate</strong> in the form of<strong> bradycardia</strong></span></span></span></p>",
      "correct_choice_id": 58015,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14554,
      "choices": [
        {
          "id": 58177,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Peripheral decarboxylase inhibitor&mdash;Benserazide</span></span></span></p>"
        },
        {
          "id": 58178,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Selective MAO- B inhibitor&mdash;Clorgyline</span></span></span></p>"
        },
        {
          "id": 58179,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">COMT inhibitor&mdash;Entacapone</span></span></span></p>"
        },
        {
          "id": 58180,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Dopamine facilitator&mdash;Amantadine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the following pairs of mechanism of action with the drug are correct except </span></span></span></p>",
      "unique_key": "Q8890139",
      "question_audio": null,
      "question_video": null,
      "map_id": 36202,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Selective MAO- B inhibitor&ndash; Clorgyline</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Clorgyline</strong> is a<strong> non-selective monoamine oxidase (MAO) inhibitor</strong> means it <strong>inhibits both MAO-A</strong> as well as <strong>MAO-B</strong> <strong>isoforms</strong>. <strong>MAO-A and MAO-B are enzymes</strong> involved in the <strong>breakdown of neurotransmitters</strong> such as <strong>dopamine,</strong> <strong>norepinephrine, and serotonin</strong>. <strong>MAO inhibitors</strong> can be <strong>used to treat depression and Parkinson&#39;s disease</strong>, as they can <strong>increase the levels </strong>of these <strong>neurotransmitters in the brain.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Benserazide</strong> is a <strong>peripheral decarboxylase inhibitor</strong> that is used in <strong>combination with levodopa </strong>to<strong> treat Parkinson&#39;s</strong> <strong>disease.</strong> It works by <strong>inhibiting the enzyme dopa decarboxylase,</strong> which <strong>converts levodopa</strong> <strong>into dopamine </strong>outside the <strong>brain</strong>. This allows<strong> more levodopa to cross the blood-brain barrier</strong> and<strong> increase dopamine levels </strong>in the brain.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Entacapone</strong> is a <strong>Catechol-O-methyltransferase (COMT) inhibitor</strong> that is<strong> used in combination with levodopa </strong>to treat <strong>Parkinson&#39;s disease</strong>. It works by<strong> inhibiting the enzyme COMT,</strong> which <strong>breaks down levodopa </strong>in the peripheral tissues. This allows <strong>more levodopa </strong>to cross the blood-brain barrier and<strong> increase dopamine levels in the brain.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Amantadine</strong> is an <strong>antiviral medication</strong> that is also <strong>used to treat Parkinson&#39;s disease</strong>. It works by <strong>increasing the release</strong> of <strong>dopamine in the brain </strong>and <strong>blocking the reuptake of dopamine</strong> into the<strong> presynaptic neuron.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14612,
      "choices": [
        {
          "id": 58409,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Valproate</span></span></span></p>"
        },
        {
          "id": 58410,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Retigabine</span></span></span></p>"
        },
        {
          "id": 58411,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Topiramate</span></span></span></p>"
        },
        {
          "id": 58412,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Vigabatrin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All the following antiepileptic drugs may cause visual problems except. </span></span></span></p>",
      "unique_key": "Q1158051",
      "question_audio": null,
      "question_video": null,
      "map_id": 36194,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Valproate</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Valproate </strong>is an <strong>antiepileptic drug</strong> that works by<strong> increasing GABA levels, blocking</strong> <strong>voltage-gated sodium channels,</strong> and <strong>inhibiting</strong> <strong>T-type calcium channels</strong>. Visual problems are <strong>not</strong> a <strong>common side effect</strong> of<strong> valproate.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>other antiepileptic</strong> drugs mentioned may cause <strong>visual problems:</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong>Other Options :</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Retigabine:</span></strong><span style=\"font-size:12.0pt\"> Retigabine is a <strong>potassium channel opener.</strong> It may cause <strong>visual</strong> <strong>disturbances</strong>, such as changes in <strong>colour vision and difficulty adjusting to darkness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Topiramate:</span></strong><span style=\"font-size:12.0pt\"> Topiramate is an <strong>antiepileptic drug</strong> that works by <strong>blocking voltage-gated sodium channels,</strong> <strong>enhancing GABA activity,</strong> and<strong> inhibiting glutamate activity</strong>. It may cause<strong> visual problems</strong>, including <strong>acute angle-closure glaucoma, myopia, and diplopia (double vision).</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Vigabatrin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vigabatrin is an <strong>antiepileptic drug</strong> that works by <strong>inhibiting GABA</strong> t<strong>ransaminase,</strong> <strong>increasing GABA levels in the brain</strong>. It may cause<strong> visual problems</strong>, such as <strong>peripheral visual field defects</strong> and <strong>retinal dysfunction.</strong></span></span></p>",
      "correct_choice_id": 58409,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14622,
      "choices": [
        {
          "id": 58449,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nicotine gums have 10-15% more bioavailability than nicotine lozenges.</span></span></span></p>"
        },
        {
          "id": 58450,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Varenicline is ideal but has a risk of cardiovascular events.</span></span></span></p>"
        },
        {
          "id": 58451,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Efficiency of nicotine gums increases after coffee or tea intake.</span></span></span></p>"
        },
        {
          "id": 58452,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nicotine replacement therapy is given only via oral route.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is true regarding smoking addiction? </span></span></span></p>",
      "unique_key": "Q6862017",
      "question_audio": null,
      "question_video": null,
      "map_id": 36196,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Varenicline is ideal but has a risk of cardiovascular events.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Varenicline</strong> is a medication<strong> used to aid</strong> in <strong>smoking cessation</strong>. It works by<strong> blocking the effects of nicotine </strong>in the brain, <strong>reducing cravings and withdrawal symptoms. </strong>Studies have shown that<strong> varenicline is more effective </strong>than<strong> nicotine replacement therapy </strong>or<strong> bupropion for smoking cessation</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">However, there is a<strong> risk of cardiovascular events </strong>associated with <strong>varenicline use</strong>, particularly in patients with<strong> pre-existing cardiovascular disease</strong>. Patients should be <strong>monitored closely for cardiovascular events </strong>while taking <strong>varenicline.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>other options </strong>are <strong>not </strong>true regarding<strong> smoking addiction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:&nbsp;&nbsp;</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Nicotine gums have 10-15% more bioavailability than nicotine lozenges</span></strong><span style=\"font-size:12.0pt\">: <strong>&nbsp;Nicotine</strong> <strong>lozenges have 10-15 %</strong> <strong>more </strong>bioavailability because some <strong>nicotine remains with gum</strong> even after t<strong>horough chewing</strong> whereas<strong> lozenges completely melt and release all nicotine present </strong>in<strong> it. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Efficiency of nicotine gums increases after coffee or tea intake</span></strong><span style=\"font-size:12.0pt\">: &nbsp;<strong>Caffeine</strong> can <strong>decrease</strong> the effectiveness of <strong>nicotine replacement therapy. </strong>Therefore, a<strong> gap of 15 minutes</strong> must be <strong>observed </strong>between<strong> use of NRT and drinking tea or coffee.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nicotine replacement therapy is given only via oral route: </span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>Nicotine replacement</strong> therapy can be given <strong>via various routes,</strong> including <strong>oral</strong> (<strong>gum, lozenge, inhaler)</strong>,<strong> transdermal</strong> <strong>patch, and nasal spray.</strong></span></span></span></p>",
      "correct_choice_id": 58450,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14461,
      "choices": [
        {
          "id": 57805,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Ropinirole </span></span></span></p>"
        },
        {
          "id": 57806,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Levodopa </span></span></span></p>"
        },
        {
          "id": 57807,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT\" style=\"font-size:12.0pt\">Bromocriptine </span></span></span></p>"
        },
        {
          "id": 57808,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Entacapone</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 65-year-old patient with a history of Parkinson&#39;s disease presents to the clinic complaining of peripheral numbness and tingling in his fingers and toes. He is currently taking medication for his Parkinson&#39;s disease, and upon further questioning, he mentions that he has noticed an increase in these symptoms since starting a new medication a few weeks ago. Which of the following anti-parkinsonian drugs is most likely to be causing the peripheral vasospasm observed in this patient?</span></span></span></p>",
      "unique_key": "Q2175909",
      "question_audio": null,
      "question_video": null,
      "map_id": 36209,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Bromocriptine.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Bromocriptine, a dopamine agonist</strong> used in the treatment o<strong>f Parkinson&#39;s disease,</strong> is known to cause <strong>peripheral vasospasm </strong>as a side effect. This can<strong> manifest as numbness, tingling, and pain in extremities </strong>due to its <strong>vasoconstrictive properties</strong>. Such<strong> side effects </strong>are p<strong>articularly </strong>concerning in<strong> patients with existing circulatory issues.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ropinirole:</span></strong><span style=\"font-size:12.0pt\"> While also a<strong> dopamine agonist</strong>, it<strong> does not </strong>commonly cause <strong>peripheral vasospasm.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Levodopa:</span></strong><span style=\"font-size:12.0pt\"> The<strong> most commonly used </strong>medication in<strong> Parkinson&#39;s treatment</strong>, known for<strong> many side effects,</strong> but<strong> peripheral</strong> <strong>vasospasm is not </strong>typically <strong>one of them.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Entacapone:</span></strong><span style=\"font-size:12.0pt\"> A <strong>COMT inhibitor</strong> used to <strong>extend the effects of Levodopa</strong>;<strong> not </strong>associated with causing<strong> peripheral vasospasm.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong><u> </u></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bromocriptine</strong> can cause<strong> peripheral vasospasm</strong> leading to symptoms like <strong>numbness and tingling in extremities, </strong>an important consideration when <strong>monitoring side effects in Parkinson&rsquo;s disease patients</strong>.</span></span></p>",
      "correct_choice_id": 57807,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14567,
      "choices": [
        {
          "id": 58229,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Opioid receptor agonist </span></span></span></p>"
        },
        {
          "id": 58230,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Opioid receptor partial agonist </span></span></span></p>"
        },
        {
          "id": 58231,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Opioid receptor antagonist </span></span></span></p>"
        },
        {
          "id": 58232,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Opioid receptor inverse agonist</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 35-year-old male patient with a history of opioid addiction presents to your clinic for treatment. He has a long history of opioid use and has recently stopped using opioids. Which of the following is the mechanism of action of methadone, the medication that is commonly used to treat opioid addiction?</span></span></p>",
      "unique_key": "Q9005272",
      "question_audio": null,
      "question_video": null,
      "map_id": 36203,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Opioid receptor agonist.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Methadone</strong> is a<strong> synthetic opioid</strong> that is primarily <strong>used to treat opioid addiction</strong> by <strong>reducing withdrawal symptoms</strong> and <strong>cravings</strong>. It works by<strong> binding to the same opioid receptors </strong>in the<strong> brain</strong> that are targeted by<strong> natural opioids</strong>, such as <strong>endorphins</strong>, to produce <strong>pain relief, euphoria, and other effects.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Opioid receptor partial agonists,</strong> such as <strong>buprenorphine</strong>, have a<strong> weaker effect</strong> on the <strong>opioid receptors </strong>than <strong>full agonists</strong> like <strong>methadone.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Opioid receptor antagonists</strong>, such as<strong> naloxone and naltrexone</strong>, <strong>block </strong>the <strong>effects of opioids</strong> and are used to <strong>treat opioid</strong> <strong>overdose </strong>and <strong>prevent relapse </strong>in individuals who have <strong>stopped using opioids.</strong></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 58229,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14515,
      "choices": [
        {
          "id": 58021,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3 and 4 are correct. </span></span></span></p>"
        },
        {
          "id": 58022,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Only 2 are correct. </span></span></span></p>"
        },
        {
          "id": 58023,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 2 are correct. </span></span></span></p>"
        },
        {
          "id": 58024,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All is correct.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chlorpromazine acts on which of the following receptors?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D2 and 5HT2 receptors </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GABA and Beta-adrenergic receptors </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Muscarinic M1 and alpha-adrenergic receptors </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H1 receptors </span></span></li>\r\n</ol>",
      "unique_key": "Q4174159",
      "question_audio": null,
      "question_video": null,
      "map_id": 36201,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) 1, 3 and 4 are correct.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Chlorpromazine,</strong> a<strong> first-generation antipsychotic</strong>, has a<strong> broad receptor profile </strong>that contributes to <strong>both its therapeutic effects</strong> and <strong>side effects:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">D2 and 5HT2 receptors:</span></strong><span style=\"font-size:12.0pt\"> It <strong>acts</strong> as an<strong> antagonist at dopamine D2</strong> and <strong>serotonin 5HT2 receptors</strong>, which helps <strong>modulate</strong> <strong>mood and psychotic symptoms.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Muscarinic M1 and alpha-adrenergic receptors:</span></strong><span style=\"font-size:12.0pt\"> It also <strong>antagonizes these receptors</strong>, contributing to<strong> side effects</strong> such as <strong>dry mouth, sedation, and hypotension.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">H1 receptors:</span></strong><span style=\"font-size:12.0pt\"> <strong>Histamine receptor antagonism</strong> leads to <strong>sedative effects</strong>, which is typical of many<strong> first-generation</strong> <strong>antipsychotics.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">GABA and Beta-adrenergic receptors:</span></strong><span style=\"font-size:12.0pt\"> <strong>Chlorpromazine</strong> <strong>does not</strong> significantly interact with these<strong> receptor types,</strong> making statement <strong>2</strong> <strong>incorrect.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Chlorpromazine&#39;s</strong> action on <strong>multiple neurotransmitter receptors</strong> explains<strong> both its efficacy</strong> in treating <strong>psychotic symptoms </strong>and <strong>its</strong> <strong>wide range</strong> of <strong>potential side effects,</strong> <strong>underscoring</strong> the importance of<strong> careful patient monitoring</strong> when using this <strong>medication.</strong></span></span></span></p>",
      "correct_choice_id": 58021,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}